Medical device maker Inogen notched $18.2 million in profits, or $1.10 per diluted share, on $75.4 million in revenue last year, the Goleta firm said in its first earnings report as a public company.
Shares of Goleta-based Inogen settled into the low $15 range as the Business Times went to press Feb. 19 after the company raised $70.5 million in an initial public offering that priced at $16, the low end of its expected range. In addition to selling shares, the company changed some of the disclosures it made to investors, pointing out its steep reliance on government and private insurance programs for 41 percent of its total revenue in 2012.
Goleta-based Inogen has boosted the amount it plans to raise in its initial public offering to a possible $91.3 million. The pricing is a sign that Inogen and its underwriters — J.P. Morgan, Leerink Partners, William Blair and Stifel — believe there’s strong demand for its shares.
By Stephen Nellis / Friday, January 17th, 2014 / Technology, Top Stories / Comments Off on New capital injection brings Suneva Medical total to $70.5M
Suneva Medical, a San Diego aesthetics company with executive offices in Santa Barbara, has raised $35 million in debt and equity financing, bringing its total funding to $70.5 million over the past two years.
By Stephen Nellis / Friday, May 24th, 2013 / Technology, Top Stories / Comments Off on TrueVision Systems steps into world of 3D with Leica deal
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Goleta-based BAROnova has raised $27.3 million to fund clinical trials of its obesity treatment, bringing the medical device firm’s total funds raised to date to $41.3 million. The company is developing a product it calls the TransPyloric Shuttle. The firm said the device may be able to slow the digestion process and create the sensation of Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
